US FDA lists Sun Pharma's Halol unit under 'import alert'The United States Food and Drug Administration (US FDA) has placed Sun Pharmaceuticals' Halol unit under 'import alert'. This implies that ...
US FDA issues Form 483 with 10 observations to Sun Pharma’s Halol unitListed pharmaceutical entity Sun Pharmaceutical Industries on Tuesday informed the exchanges that the US FDA has issued Form 483 with ten o...
MG Motor India to invest Rs 4,000 crore for a second manufacturing plantWhen asked about the investment and production capacity for the second plant, he said, "We are looking for close to Rs 4,000 crore for the ...
MG Motor India to shut Halol manufacturing unit for 7 days to curb COVID-19 spread"We have decided to close our plant in Halol @Vadodra for seven days to break the chain of COVID. And our employees are committed to stay s...
Chinese automaker SAIC may invest $350m, its subsidiary to launch 4 vehiclesMG Motor India plans to launch four vehicles in the country over the next two years. The final decision regarding the second unit will be t...
Sun Pharma shares rally after USFDA reclassifies Halol Unit as 'No Action Initiated'USFDA no action initiated status means clearance for the unit.
If Sun Pharma inspections come through, 2018 could be a turning point for Indian pharma: Amit Rajan, Prosfora Technology“We have to get our things in order for sterile manufacturing and Sun Pharma Halol plant is mostly on steriles.”
USFDA report on Halol unit to be positive in long-term: SunThe company's Halol facility recently underwent an inspection by the US Food and Drug Administration (USFDA).
US FDA finds fault with Sun’s testing programmes at HalolAn FDA audit of the Sun Pharma unit between November 17 and December 1 has revealed inadequately designed testing programmes to assess the ...
USFDA made 9 observations post Halol unit inspection: Sun PharmaThe United States Food and Drug Administration (USFDA) inspected the Halol facility from November 17, 2016 through December 1, 2016, Sun Ph...
FDA issues observations post Sun Pharma Halol plant inspectionThe approval of several of Sun's key drugs in the United States, the drugmaker's biggest market, depends on the clearance on its Halol plan...
Sun Pharma surges 3% on Halol unit re-inspectionAs per estimates, the Halol site that produces a range of products from tablets to nasal sprays, contributes over 15% of Sun Pharma's reven...
Sun Pharma to ask FDA in Q1 FY17 for Halol re-inspectionDrug major Sun Pharmaceutical Industries may ask the US health regulator in the first quarter of next fiscal for re-inspection of its Halol...
Sun Pharma stock slumps 7%, SPARC 6%Shares of Sun Pharma and SPARC took a beating in Monday’s trade, falling as much as 7%, after the US FDA issued a warning letter to former’...
Jefferies maintains buy call on Sun pharma despite adverse guidanceJefferies said it is positive about Sun Pharma's strong key fundamentals, though its stock plunged 15 per cent today.
Sun Pharma falls 6% as USFDA inspects Halol unit; facility contributes 40% of US salesThe facility is important for the company as its contributes to around 40 per cent of US sales and around 25 per cent of consolidated profi...
- GM India to hire 1,000 people by 2012, expand output by 80 per cent
GM India said it will hire about 1,000 people by 2012, in line with its plans to expand the current production capacity by over 80 per cent...